Neurodon is a brand dedicated to targeting cellular stress and revolutionizing medicine. By treating cellular stress at its root, Neurodon develops disease-modifying therapeutics that have the potential to positively impact patients' lives. They emphasize the importance of cellular calcium balance, which plays a crucial role in maintaining overall health and fighting diseases such as diabetes, Alzheimer's, Parkinson's, and muscular dystrophy.

Neurodon's research focuses on regulating impaired transport of cellular calcium to relieve stress pathways. The discovery of Neurodon's small molecules has been a significant breakthrough after decades of attempts by other teams to develop molecules that normalize calcium transport. Neurodon's approach targets the SERCA enzyme, which is responsible for maintaining calcium balance in cells and has shown impairment in various diseases.

By allosterically modulating the SERCA enzyme conformation, Neurodon's proprietary small molecules accelerate calcium transport into the endoplasmic reticulum (ER), relieving ER stress and promoting cellular health. Neurodon's success has been made possible through the support of partners and investors. Their groundbreaking research in disease-modifying therapeutics has the potential to revolutionize medicine and improve the lives of countless individuals